The number of tumor-infiltrating CD3+ and CD25+ cells positively correlates with clinical response to rituximab in follicular lymphoma patients Park, C. Y., Bohen, S. P., Levy, R., Warnke, R., Natkunam, Y. NATURE PUBLISHING GROUP. 2005: 245A

View details for Web of Science ID 000226117901288